Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ziprasidone injection combined with oral antipsychotics for acute agitation in schizophrenia
ChiCTR1900023483Phase 4Recruiting
- Sponsor
- Xi'an Mental Health Center
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ziprasidone, olanzapine and aripiprazole in schizophrenia (2 arms), sponsored by Xi'an Mental Health Center. Primary endpoint: PANSS-EC. Started Jun 2019; status: recruiting.
02
Drugs
ziprasidoneolanzapinearipiprazole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on ChiCTR1900023483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900023483.